Free Trial
→ Trump Predicts Dollar Downfall (From Augusta Precious Metals) (Ad) Buy NBY Stock  Free NBY Stock Alerts

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

NovaBay Pharmaceuticals logo
$0.56 0.00 (-0.58%)
As of 03:57 PM Eastern
Compare

Recent NovaBay Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/15/2025
11:40 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:46 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:50 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:11 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:18 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:22 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:30 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:30 PM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:33 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEF 14A
03/11/2025
3:35 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:07 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:08 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
02/06/2025
5:30 PM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:58 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:58 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:12 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:13 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:06 PM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/10/2025
6:03 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
6:00 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:12 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
12/09/2024
6:05 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/26/2024
3:08 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/22/2024
3:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:10 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:15 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/12/2024
3:52 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/08/2024
4:31 PM		Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
3:46 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:15 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:19 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
10/16/2024
3:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:19 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFM14A
09/25/2024
4:17 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form PREM14A
09/20/2024
7:08 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:08 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
07/29/2024
3:25 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
6:18 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 424B4
07/26/2024
4:19 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form POS EX
07/25/2024
11:15 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form EFFECT
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
07/24/2024
7:49 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
07/12/2024
5:21 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
07/11/2024
7:50 AM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form FWP
07/11/2024
7:45 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:05 PM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form FWP
07/10/2024
8:30 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
06/28/2024
3:21 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 424B3
06/28/2024
2:19 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/27/2024
11:15 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form EFFECT
06/21/2024
4:26 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/20/2024
4:12 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/14/2024
7:47 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:30 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:50 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:43 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K/A
05/30/2024
8:24 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:27 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Sit Swan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:29 PM		Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:31 PM		Garlikov Julie (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:17 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yongxiang (Reporting)
Zheng Yongxiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:22 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yenyou (Reporting)
Zheng Yenyou (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:NBY) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
The “supermetal” that could power AI
While the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...
True Market Insiders | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Trump Quietly Planning $15 Trillion Crypto Shocker
Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...
Paradigm Press | Sponsored
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored